{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:47:48Z","timestamp":1754110068361,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00417-019-04488-8","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T13:24:17Z","timestamp":1571837057000},"page":"2671-2676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs)"],"prefix":"10.1007","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-0226","authenticated-orcid":false,"given":"Irina S.","family":"Barequet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzukit","family":"Zehavi-Dorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirit","family":"Bourla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilia","family":"Tamarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Moisseiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ophira","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"19","key":"4488_CR1","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369\u20132429. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehq278","journal-title":"Eur Heart J"},{"issue":"21","key":"4488_CR2","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines (CPG) (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719\u20132747. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehs253","journal-title":"Eur Heart J"},{"issue":"1","key":"4488_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1055\/s-0036-1597831","volume":"38","author":"J Weitz","year":"2017","unstructured":"Weitz J (2017) Reversal of direct oral anticoagulants: current status and future directions. Semin Respir Crit Care Med 38(1):40\u201350. \nhttps:\/\/doi.org\/10.1055\/s-0036-1597831","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"4488_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/IAE.0000000000000783","volume":"36","author":"MG Grand","year":"2016","unstructured":"Grand MG, Walia HS (2016) Hemorrhagic risk of vitreoretinal surgery in patients maintained on novel oral anticoagulant therapy. Retina. 36(2):299\u2013304. \nhttps:\/\/doi.org\/10.1097\/IAE.0000000000000783","journal-title":"Retina."},{"issue":"7","key":"4488_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00417-017-3664-3","volume":"255","author":"R Patel","year":"2017","unstructured":"Patel R, Charles S, Jalil A (2017) Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review. Graefes Arch Clin Exp Ophthalmol 255(7):1275\u20131285. \nhttps:\/\/doi.org\/10.1007\/s00417-017-3664-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"4488_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/jamaophthalmol.2015.0985","volume":"133","author":"D Caldeira","year":"2015","unstructured":"Caldeira D, Canastro M, Barra M, Ferreira A, Costa J, Pinto FJ, Ferreira JJ (2015) Risk of substantial intraocular bleeding with novel oral anticoagulants: systemic review and meta-analysis. JAMA Ophthalmol 133(7):834\u2013839. \nhttps:\/\/doi.org\/10.1001\/jamaophthalmol.2015.0985","journal-title":"JAMA Ophthalmol"},{"issue":"25","key":"4488_CR7","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1182\/blood-2014-08-595496","volume":"124","author":"D Garcia","year":"2014","unstructured":"Garcia D, Alexander JH, Wallentin L, Wojdyla DM, Thomas L, Hanna M, Al-Khatib SM, Dorian P, Ansell J, Commerford P et al (2014) Management and clinical outcomes in patients treated with apixaban vs. warfarin undergoing procedures. Blood. 124(25):3692\u20133698. \nhttps:\/\/doi.org\/10.1182\/blood-2014-08-595496","journal-title":"Blood."},{"issue":"9","key":"4488_CR8","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/S0161-6420(03)00785-1","volume":"110","author":"J Katz","year":"2003","unstructured":"Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, Fleisher LA, Schein OD, Study of Medical Testing for Cataract Surgery Team (2003) Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology. 110(9):1784\u20131788","journal-title":"Ophthalmology."},{"issue":"5","key":"4488_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ajo.2007.07.029","volume":"144","author":"IS Barequet","year":"2007","unstructured":"Barequet IS, Sachs D, Priel A, Wasserzug Y, Martinowitz U, Moisseiev J, Salomon O (2007) Phacoemulsification of cataract in patients receiving coumadin therapy: ocular and hematologic risk assessment. Am J Ophthalmol 144(5):719\u2013723","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"4488_CR10","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jcrs.2011.02.035","volume":"37","author":"IS Barequet","year":"2011","unstructured":"Barequet IS, Sachs D, Shenkman B, Priel A, Wasserzug Y, Budnik I, Moisseiev J, Salomon O (2011) Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy. J Cataract Refract Surg 37(8):1434\u20131438. \nhttps:\/\/doi.org\/10.1016\/j.jcrs.2011.02.035","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"4488_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/ICU.0000000000000117","volume":"26","author":"A Grzybowski","year":"2015","unstructured":"Grzybowski A, Ascaso FJ, Kupidura-Majewski K, Packer M (2015) Continuation of anticoagulant and antiplatelet therapy during phacoemulsification cataract surgery. Curr Opin Ophthalmol 26(1):28\u201333. \nhttps:\/\/doi.org\/10.1097\/ICU.0000000000000117","journal-title":"Curr Opin Ophthalmol"},{"issue":"10","key":"4488_CR12","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.jcrs.2009.05.042","volume":"35","author":"R Batra","year":"2009","unstructured":"Batra R, Maino A, Ch\u2019ng SW, Marsh IB (2009) Perioperative management of anticoagulated patients having cataract surgery: national audit of current practice of members of the Royal College of Ophthalmologists. J Cataract Refract Surg 35(10):1815\u20131820. \nhttps:\/\/doi.org\/10.1016\/j.jcrs.2009.05.042","journal-title":"J Cataract Refract Surg"},{"issue":"22","key":"4488_CR13","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMra1206531","volume":"368","author":"TH Baron","year":"2013","unstructured":"Baron TH, Kamath PS, McBane RD (2013) Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med 368(22):2113\u20132124. \nhttps:\/\/doi.org\/10.1056\/NEJMra1206531","journal-title":"N Engl J Med"},{"issue":"5","key":"4488_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jcrs.2004.09.058","volume":"31","author":"L Ong-Tone","year":"2005","unstructured":"Ong-Tone L, Paluck EC, Hart-Mitchell RD (2005) Perioperative use of warfarin and aspirin in cataract surgery by Canadian Society of Cataract and Refractive Surgery members: survey. J Cataract Refract Surg 31(5):991\u2013996","journal-title":"J Cataract Refract Surg"},{"issue":"12","key":"4488_CR15","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/imj.13513","volume":"47","author":"H Wamala","year":"2017","unstructured":"Wamala H, Scott IA, Caney X (2017) Perioperative management of new oral anticoagulants in patients undergoing elective surgery at a tertiary hospital. Intern Med J 47(12):1412\u20131421. \nhttps:\/\/doi.org\/10.1111\/imj.13513","journal-title":"Intern Med J"},{"issue":"6","key":"4488_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1502000","volume":"373","author":"CV Pollack Jr","year":"2015","unstructured":"Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW et al (2015) Idarucizumab for dabigatran reversal. N Engl J Med 373(6):511\u2013520. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1502000","journal-title":"N Engl J Med"},{"issue":"10","key":"4488_CR17","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1161\/ATVBAHA.117.306995","volume":"37","author":"M Hoffman","year":"2017","unstructured":"Hoffman M, Monroe DM (2017) Impact of non-vitamin K antagonist oral anticoagulants from a basic science perspective. Arterioscler Thromb Vasc Biol 37(10):1812\u20131318. \nhttps:\/\/doi.org\/10.1161\/ATVBAHA.117.306995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"4488_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/aos.13186","volume":"94","author":"VC Mulder","year":"2016","unstructured":"Mulder VC, Kluft C, van Meurs JC (2016) Vitreous and subretinal fluid concentrations of orally administered dabigatran in patients with rhegmatogenous retinal detachment. Acta Ophthalmol 94(7):663\u2013667. \nhttps:\/\/doi.org\/10.1111\/aos.13186","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"4488_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1001\/jamaophthalmol.2017.5677","volume":"136","author":"KE Uyhazi","year":"2018","unstructured":"Uyhazi KE, Miano T, Pan W, VanderBeek BL (2018) Association of novel oral antithrombotics with the risk of intraocular bleeding. JAMA Ophthalmol 136(2):122\u2013130. \nhttps:\/\/doi.org\/10.1001\/jamaophthalmol.2017.5677","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"4488_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/eye.2016.265","volume":"31","author":"G Talany","year":"2017","unstructured":"Talany G, Guo M, Etminan M (2017) Risk of intraocular hemorrhage with new oral anticoagulants. Eye (Lond) 31(4):628\u2013631. \nhttps:\/\/doi.org\/10.1038\/eye.2016.265","journal-title":"Eye (Lond)"},{"issue":"1","key":"4488_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3928\/23258160-20151214-13","volume":"47","author":"K Wang","year":"2016","unstructured":"Wang K, Ehlers JP (2016) Bilateral spontaneous hyphema, vitreous hemorrhage, and choroidal detachment with concurrent dabigatran etexilate therapy. Ophthalmic Surg Lasers Imaging Retina 47(1):78\u201380. \nhttps:\/\/doi.org\/10.3928\/23258160-20151214-13","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"4488_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/2042098613507945","volume":"5","author":"JA V\u00edlchez","year":"2014","unstructured":"V\u00edlchez JA, Gallego P, Lip GY (2014) Safety of new oral anticoagulant drugs: a perspective. Ther Adv Drug Saf 5(1):8\u201320. \nhttps:\/\/doi.org\/10.1177\/2042098613507945","journal-title":"Ther Adv Drug Saf"},{"issue":"5","key":"4488_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1056\/NEJMoa1707278","volume":"377","author":"CV Pollack Jr","year":"2017","unstructured":"Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW et al (2017) Idarucizumab for dabigatran reversal \u2013full cohort analysis. N Engl J Med 377(5):431\u2013441. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1707278","journal-title":"N Engl J Med"},{"issue":"3","key":"4488_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10792-018-0862-x","volume":"39","author":"JJC Cheung","year":"2019","unstructured":"Cheung JJC, Liu S, Li KKW (2019) Phacoemulsification cataract surgery in patients receiving novel oral anticoagulant medications. Int Ophthalmol 39(3):623\u2013630. \nhttps:\/\/doi.org\/10.1007\/s10792-018-0862-x","journal-title":"Int Ophthalmol"},{"issue":"3","key":"4488_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00417-017-3897-1","volume":"256","author":"C Meillon","year":"2018","unstructured":"Meillon C, Gabrielle PH, Luu M, Aho-Glele LS, Bron AM, Creuzot-Garcher C, CFSR research net (2018) Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients. Graefes Arch Clin Exp Ophthalmol 256(3):461\u2013467. \nhttps:\/\/doi.org\/10.1007\/s00417-017-3897-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04488-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04488-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04488-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:14:17Z","timestamp":1603235657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04488-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4488"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04488-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"13 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed were in accordance with the ethical standards of the (Review Board of the Sheba Medical Center) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}